ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 393

Influence of Body Mass Index on Disease Activity and Radiographic Joint Damage in Rheumatoid Arthritis : A Systematic Review and Meta-Analysis

Celine Vidal1, Thomas Barnetche2, Jacques Morel3, Bernard Combe4 and Claire Daien5, 1Rheumatology, Hopital Lapeyronie, Montpellier, France, 2rheumatology, Rheumatology department, Bordeaux University Hospital, bordeaux, France, 3Department of Rheumatology, Hôpital Lapeyronie, Montpellier, France, 4Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, 5Hopital Lapeyronie, Montpellier, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Disease Activity, obesity, radiography and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects: Novel Biomarkers and Other Measurements of Disease Activity

Session Type: Abstract Submissions (ACR)

Background/Purpose: Overweight and obesity in patients with rheumatoid arthritis (RA) are rising conditions. Adipose tissue has pro inflammatory properties by producing adipokines which could play a role in RA activity. The prognosis of overweight and obese patients with RA is not well established.

Methods: We conducted a systematic review and meta-analysis to assess the influence of body mass index on disease activity (DAS 28) and radiographic joint damage (RJD) in patients with RA. We searched MEDLINE and The Cochrane Database publications up to April 2014 with MeSH terms (“body mass index” OR “obese”) AND “rheumatoid arthritis”. Studies reporting DAS 28 and/or its components,Health Assesment Questionnaire (HAQ) and RJD according to body mass index (BMI)groups were included. Two investigators abstracted data and rated study quality and applicability. Statistical analysis used weighted mean differences with a fixed or random effects model, except for radiographic analysis in which standardized means were used as different radiographic scores were assessed in studies.

Results: Among the 579 citations retrieved with MeSH terms, 52 articles suited inclusion criteria and 7 of them were included in meta-analysis. Activity was assessed in 4 studies, involving 1402 patients, and revealed an association between obesity in RA and higher DAS 28 (+ 0.14, p=0.04, I²=0%).Health Assessment Questionnaire (HAQ) was evaluated in 2 studies, involving 1264 patients, and also revealed a positive association with obesity  (+ 0.1, p=0.03, I²=0%). RJD was reported in 4 studies, involving 1465 patients, revealing a negative association with obesity (p=0.03, I²=38%). According to the systematic review, the increase of DAS 28 could be explained by an increase of tender joint counts and global health assessment.

Conclusion: Obesity in RA is associated with higher DAS 28 and HAQ. However, obese patients with RA have lower RJD. This increase of DAS28 in obese patients could be explained by pro inflammatory fat cytokines or the general tendency of higher pain levels due to comorbidities resulting from obesity. Conversely, the increase of adiponectine observed in obese patients may play a protective role on joint damage. Altogether, this work highlights the importance of obesity on RA prognosis and supports the need of future studies to better understand the mechanisms behind.


Disclosure:

C. Vidal,
None;

T. Barnetche,
None;

J. Morel,
None;

B. Combe,
None;

C. Daien,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/influence-of-body-mass-index-on-disease-activity-and-radiographic-joint-damage-in-rheumatoid-arthritis-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology